Sign in
CompletedNo phase

Contingency Management to Promote Smoking Cessation

Key facts

Who runs it
University of Kansas Medical Center
Where
Kansas City, United StatesSee the site
Trial code
Status
Completed
People taking part
20 people enrolled
Started
11 Sept 2024
Ended
30 Jan 2026
Type of study
Interventional
Treatments tested
  • CounsCM+MedCM (Health Rewards)
Record updated
17 June 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Smoked in the past 30 days
  • Smoke at least 1 cigarette per day when they smoke
  • ≥ 18 years old
  • Kansas resident
  • Speak/read English
  • Access to a mobile phone
  • Mobile phone receives text messages
  • No varenicline contraindications (no acute renal impairment)
  • Insurance coverage for varenicline
  • Have no significant co-morbidity (i.e., life-threatening illness, communication barriers or altered mental status)
  • Cognitively able to participate
  • Physically able to participate
  • Not pregnant/breastfeeding

Who cannot take part

  • Patient on smoking cessation medication within 2 weeks of admission date
  • Medically ineligible for varenicline
  • Patient already talked to quitline in the past 2 weeks
  • Patients participating in other quit smoking program or research study

Where in United States

  • University of Kansas Medical CenterKansas City, United States

About the trial

What the trial wants to find out

Many hospitals and outpatient clinics often refer people who smoke to quitlines and provide prescriptions for smoking cessation medications, but patients rarely fully engage in counseling or use their cessation medications. This is a single-arm, open-label pilot study to provide feasibility metrics for a text-based contingency management (CM) intervention to increase engagement in smoking cessation treatment. All participants (N=20) will be referred to a state quitline and will receive a prescription for medication plus 12 weeks of a text-based CM intervention to increase engagement in quitline calls and varenicline utilization. The engagement of participants in quitline counseling will be tracked for 6 weeks and medication utilization for 12 weeks post-enrollment. The investigators will use mixed-methods to collect implementation and acceptability data to inform changes to the text-based contingency management (CM) intervention.

The group in the trial

  • MedCM plus CounsCMTreatment being tested

    Mobile Contingency Management for counseling attendance and medication intake

    Treatment: CounsCM+MedCM (Health Rewards)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
17 June 2026